Pharmacology and therapeutics

Pharmacology and therapeutics

Perspectives
Endocrinology Today
March 2022
2022; 11(1): 22-26
Glucagon-like peptide-1 receptor agonists – practical use in type 2 diabetes
Yeung-Ae Park, Christopher J. Yates, RAHUL D. BARMANRAY
Perspectives
Endocrinology Today
March 2022
2022; 11(1): 17-20
Medication-induced thyroid dysfunction: a guide to management
Bridget Cooper, Ayanthi A. Wijewardene, Christopher A. Muir
Perspectives
Endocrinology Today
November 2021
2021; 10(4): 20-25
Anabolic therapy: a new paradigm for osteoporosis management
Albert S. Kim, Christian M. Girgis
Perspectives
Endocrinology Today
August 2021
2021; 10(3): 29-32
Niche oral agents in type 2 diabetes
Ryan Jalleh, Stephen Stranks
Perspectives
Endocrinology Today
February 2021
2021; 10(1): 20-24
Adjunctive metformin in type 1 diabetes
Alicia Jenkins, Andrzej Januszewski, Gary Wittert
Endocrinology Today
February 2021
2021; 10(1): 14-18
Hormonal contraception: what’s new?
Deborah Bateson, Kathleen McNamee
Endocrinology Today
October 2020
2020; 9(4): 12-17
Established CVD in people with type 2 diabetes: what pharmacotherapy should be considered?
Kenrick Blaker, Roger Chen
Perspectives
Endocrinology Today
August 2020
2020; 9(3): 29-32
Endocrinopathies of lithium: common and treatable
Lydia S. Lamb, Katherine Samaras
Perspectives
Endocrinology Today
August 2020
2020; 9(3): 25-27
Continuous glucose monitoring technology: understanding the benefits
Amin Sharifi, Neale D. Cohen
Perspectives
Endocrinology Today
May 2020
2020; 9(2): 19-22
Newer insulins in diabetes and their clinical utility
Ashish Munsif, Roger Chen
Perspectives
Endocrinology Today
February 2020
2020; 9(1): 27-29
Complementary medicines and diabetes: benefits, safety and risk
Trisha Dunning
Perspectives
Endocrinology Today
February 2020
2020; 9(1): 23-25
An update on GLP-1 agonists: where do they fit in the type 2 diabetes management algorithm?
Timothy M.E. Davis
Endocrinology Today
February 2020
2020; 9(1): 14-21
Growth hormone replacement therapy in adults: when does it have a role?
Emily K. Brooks, Warrick J. Inder
Perspectives
Endocrinology Today
November 2019
2019; 8(4): 26-31
Evolution of type 2 diabetes management algorithms: where are we now?
Yoon Ji Jina Rhou, Ted Wu
Acute endocrine presentations in general practice
Endocrinology Today
August 2019
2019; 8(3): 33-36
A serious complication of SGLT-2 inhibitor therapy in type 2 diabetes
Sue Lynn Lau, Christian M. Girgis
Perspectives
Endocrinology Today
August 2019
2019; 8(3): 22-26
Testosterone replacement therapy: a practical guide to initiation and monitoring
Stella Sarlos, Carolyn A. Allan
Endocrinology Today
August 2019
2019; 8(3): 12-20
Postmenopausal osteoporosis: is there a role for menopausal hormone therapy?
Andrea Fernandes, Christina Jang, Emma Duncan
Endocrinology Today
May 2019
2019; 8(2): 14-20
Menopausal hormone therapy: current recommendations
Madhuni Herath, Beverley Vollenhoven
Acute endocrine presentations in general practice
Endocrinology Today
March 2019
2019; 8(1): 37-40
Endocrine immune-related adverse events
VENESSA H. TSANG, Bernard Champion
Endocrinology Today
August 2018
2018; 7(3): 23-27
Type 2 diabetes. Assessing and optimising medication adherence
Ines Krass, Kevin Mc Namara
Perspectives
Endocrinology Today
May 2018
2018; 7(2): 38-42
Ovulation induction: when and how to use it
Vicki Nisenblat, M. Louise Hull
Perspectives
Endocrinology Today
May 2018
2018; 7(2): 34-36
Statin intolerance in people with diabetes: a clinical approach
Alicia Jenkins, David O’Neal
Endocrinology Today
May 2018
2018; 7(2): 26-32
Type 2 diabetes: initiating insulin in primary care
Jo-Anne Manski-Nankervis, John Furler, David O’Neal
Perspectives
Endocrinology Today
November 2017
2017; 6(4): 27-30
New agents to treat type 2 diabetes
Ted Wu
Perspectives
Endocrinology Today
July 2017
2017; 6(3): 22-26
Digital tools for optimising diabetes self-management
nATAlie WiSCHer, SOFIANOS ANDRIKOPULOS